Patent ID: 9579409
Date: 2017-02-28
CPC Classifications: A61K,A61P

Claim:
1. A therapeutical composition, comprising a complex having the following formula (1) comprising a rare-earth radioisotope, said complex being solubilized in a lipophilic organic phase: wherein: M designates the rare-earth radioisotope, wherein the rare-earth radioisotope is L designates a tropolone ligand or a tropolone-derived ligand chosen from amongst halogenotropolone, α-methyltropolone, β-methyltropolone, γ-methyltropolone, α-isopropyltropolone, β-isopropyltropolone, γ-isopropyltropolone, nootkatin, stipitatic acid, puberulic acid, puberulonic acid, purpurogallin, or colchicine.